FGC
CRL icon

Financial Gravity Companies’s Charles River Laboratories CRL Stock Holding History

Financial Gravity Companies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$3K Buy
+22
New +$2.75K ﹤0.01% 816
2018
Q1 		$2K Sell
23
-299
-93% -$32.2K ﹤0.01% 930
2017
Q4 		$34K Buy
+322
New +$35K 0.04% 398

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Financial Gravity Companies's CRL Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Charles River Laboratories (CRL) in Q4 2018: 22 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #816 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in CRL as recently as Q1 2018.

Financial Gravity Companies first reported a position in CRL in Q4 2017 and has held it in 3 quarters since. The position peaked at $34K in Q4 2017. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

  • Financial Gravity Companies held 22 shares of Charles River Laboratories worth $3K as of Q4 2018.
  • Charles River Laboratories was a new Financial Gravity Companies position in Q4 2018.
  • Charles River Laboratories made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #816 holding.
  • Financial Gravity Companies first reported a position in Charles River Laboratories in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Charles River Laboratories position peaked at $34K in Q4 2017.
  • 407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.